| Literature DB >> 16982834 |
David A Chalton1, Julie A Musson, Helen Flick-Smith, Nicola Walker, Alistair McGregor, Heather K Lamb, E Diane Williamson, Julie Miller, John H Robinson, Jeremy H Lakey.
Abstract
Caf1, a chaperone-usher protein from Yersinia pestis, is a major protective antigen in the development of subunit vaccines against plague. However, recombinant Caf1 forms polymers of indeterminate size. We report the conversion of Caf1 from a polymer to a monomer by circular permutation of the gene. Biophysical evaluation confirmed that the engineered Caf1 was a folded monomer. We compared the immunogenicity of the engineered monomer with polymeric Caf1 in antigen presentation assays to CD4 T-cell hybridomas in vitro, as well as in the induction of antibody responses and protection against subcutaneous challenge with Y. pestis in vivo. In C57BL/6 mice, for which the major H-2(b)-restricted immunodominant CD4 T-cell epitopes were intact in the engineered monomer, immunogenicity and protective efficacy were preserved, although antibody titers were decreased 10-fold. Disruption of an H-2(d)-restricted immunodominant CD4 T-cell epitope during circular permutation resulted in a compromised T-cell response, a low postvaccination antibody titer, and a lack of protection of BALB/c mice. The use of circular permutation in vaccine design has not been reported previously.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16982834 PMCID: PMC1698084 DOI: 10.1128/IAI.00437-06
Source DB: PubMed Journal: Infect Immun ISSN: 0019-9567 Impact factor: 3.441